Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study

INTRODUCTION: Almost one-quarter of Asian patients with diabetes experience diabetic peripheral neuropathic pain (DPNP), which may be associated with moderate or severe levels of pain, insomnia, mood disorders, and worsened quality of life. Current treatments are generally ineffective and may be poo...

Descripción completa

Detalles Bibliográficos
Autores principales: Baba, Masayuki, Kuroha, Masanori, Ohwada, Shoichi, Murayama, Emiko, Matsui, Norimitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203334/
https://www.ncbi.nlm.nih.gov/pubmed/32052264
http://dx.doi.org/10.1007/s40122-020-00156-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203334/
https://www.ncbi.nlm.nih.gov/pubmed/32052264
http://dx.doi.org/10.1007/s40122-020-00156-6

Ejemplares similares